The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles-Reference-Cited by-同舟云学术

The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles

Published:2021-10-11 Issue: Volume: Page:
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Wiwatchaitawee Kanawat,Mekkawy Aml I.,Quarterman Juliana C.,Naguib Youssef W.,Ebeid Kareem,Geary Sean M.,Salem Aliasger K.^ORCID

Funder

national institutes of health

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-021-01065-7.pdf

Reference52 articles.

1. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37–40.

2. Pearson G, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions*. Endocr Rev. 2001;22(2):153–83.

3. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12(1):9–18.

4. Munshi A, Ramesh R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer. 2013;4(9–10):401–8.

5. Li L, et al. The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC (Review). Oncol Lett. 2016;12(5):3045–50.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CA-g-CS/PLA film packaging improved storage stability through the MAPK signaling pathway of postharvest Agaricus bisporus;Postharvest Biology and Technology;2024-03

2. Erbin Regulates Tissue Factors Through Ras/Raf Pathway in Coagulation Disorders in Sepsis;2024

3. Tuning the Emulsion Properties Influences the Size of Poly(Caprolactone) Particles for Drug Delivery Applications;The AAPS Journal;2023-10-27

4. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance;Cancer and Metastasis Reviews;2023-07-28

5. Particles and Prejudice: Nanomedicine Approaches to Reducing Health Disparities in Endometrial Cancer;Small;2023-06-13